* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download EP5.2.2 Renal Transplant Council Meeting Minutes
Adherence (medicine) wikipedia , lookup
Pharmacognosy wikipedia , lookup
Neuropharmacology wikipedia , lookup
List of comic book drugs wikipedia , lookup
Compounding wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Electronic prescribing wikipedia , lookup
Drug design wikipedia , lookup
Drug interaction wikipedia , lookup
Drug discovery wikipedia , lookup
Prescription costs wikipedia , lookup
Theralizumab wikipedia , lookup
Page 1 KIDNEY TRANSPLANT COUNCIL Meeting Date: July 16, 2014 7:45 am – 9:00am – CR-1 SFDB Co-Chairs: Margaret Fitzsimmons & Kim Lawrence Facilitator: Gemma Seidl MINUTES COMMENTS/DISCUSSION/ RECOMMENDATIONS/MOTIONS (AIM) TOPIC / AGENDA ITEM WELCOME/INTRODUCTIONS REFLECTION ATTENDANCE REVIEW MINUTES OF LAST MEETING PHARMACY UPDATE Maggie opened the meeting at 7:52 a.m. and welcomed everyone. She introduced our new attendees, Loman Poarch (DSU nights), Brooke Baitch (ICU days), and Luke (Joseph) Coleongco (MICU nights). Vivian Norman passed out individual reflections from Meditations from the Heart, and each person read theirs out loud. See below Minutes of the May 21st meeting were sent electronically by Kim Lawrence and accepted as written. Peter Hosseinpour related the medication events and adverse drug reactions since the last meeting. There were six med events and two drug reactions. Peter noted that five of the med events occurred before the June 1, 2014 MediTech upgrade, and one med event was caused by the MediTech upgrade. Med Events: 1. Severity 0, MICU. Drug: DDAVP This was a dispensing issue related to a pre-med for a kidney biopsy. The pharmacist dispensed the drug in a syringe as straight drug. The drug is typically diluted in 50 ml of NS and dispensed as an IVPB. The nurse noticed the error and requested the drug be prepared as an IVPB. This lead to a delay in doing the procedure. The orders may have been misinterpreted by the pharmacist because it was typed as “DDAVP 24 MCG IV.” 2. Severity 1, DSU. Drug: Cellcept IV This was a missed dose. The medication was on hold pending the placement of an enteral tube. When the enteral tube was not placed, APPROVALS/ ACTIONS (Plan) RESPONSIBLE PARTY / FOLLOW UP (Do-Check-Act) Maggie Fitzsimmons Vivian Norman Maggie Fitzsimmons Peter Hosseinpour Page 2 TOPIC / AGENDA ITEM COMMENTS/DISCUSSION/ RECOMMENDATIONS/MOTIONS (AIM) APPROVALS/ ACTIONS (Plan) RESPONSIBLE PARTY / FOLLOW UP (Do-Check-Act) the order was restarted at 21:39. Because it was restarted after 21:00, the computer assigned a due time of 9:00 a.m. the next day. The night nurse gave the drug that night but “stole” the 9:00 a.m. dose when he/she charted on the eMAR. As a result, the 9:00 a.m. dose did NOT pink up and was thus missed. 3. Severity 1, Med-Tele. Drug: Cyclosporin suspension This was a dispensing error. The drug comes in a bulk bottle, and the bottle did not have an expiration sticker on it as is required. 4. Severity 1, DSU. Drug: Prograf This was an order entry issue by the Pharmacy. The pharmacist applied the medication slider to this drug in error. This resulted in a dose being given at 15:00 vs. 21:00. The 21:00 dose was held, and drug levels were stable. 5. Severity 1, OR/PACU. Drug: Heparin infusion The issue here was that the drug was labeled incorrectly. It appears that the anesthesiologist mixed up a bag of Heparin but did not label the bag correctly (i.e., hard to read the concentration, no prep date, no expiration date, etc.) 6. (Under the new MediTech system) Severity 2, Med-Tele. Drug: Valcyte/Bactrim The issue was missed doses due to a MediTech build error. Both drugs were ordered to be given using the sig “Q48HR.” This sig did not have time associated with it in MediTech; thus it never pinked up for the nurse, and the doses were missed. The issue has been resolved. Adverse Drug Reactions: 1. Severity 3, MICU. Drug: Thymoglobulin Page 3 TOPIC / AGENDA ITEM COMMENTS/DISCUSSION/ RECOMMENDATIONS/MOTIONS (AIM) APPROVALS/ ACTIONS (Plan) RESPONSIBLE PARTY / FOLLOW UP (Do-Check-Act) Reaction: Head/neck pain. Chest pain, burning up spine. Treatment: Hydrocortisone, drug stopped, Morphine, EKG. No permanent harm. 2. Severity 3, ICU. Drug: Rituxan Reaction: Swollen jaw, chest pressure, itching, restlessness. LAB UPDATE DATA SCORECARD/ACTIVITY NEW BUSINESS Treatment: Drug stopped, Benadryl, Hydrocortisone, MD notified. Drug was infused at a slower rate once reaction cleared. No permanent harm. Sheila reported that there was only one lab update since the last meeting, and it was last week. We made the turnaround time in 50 minutes with a transplant patient. The patient went to MICU, and the nurse there was not a transplant nurse. The labs on the pre-transplant patient were delayed in getting to the lab. The usual transplant sticker wasn’t placed on the lab bag, so the patient was not identified as a transplant patient. Lab was not notified prior to the Labs being drawn that we had a patient being ready to be transplanted. Usually once notified both Phlebotomy and Processing are alerted which makes the process go smoother and faster. Kim advised that the data scorecard information gets reported to Dialysis and Transplant Committee, and there were no failures in 2014 until the month of May. There was one patient, which equates to a 25% failure related to the documentation of ABO type prior to listing the patient in UNOS. The process for ABO documentations was reviewed with all RNs in transplant. The correction action for this was, 2nd ABO verification will now occur in Transplant Committee by an RN when the patient is ready to be listed in UNOs for Transplant candidacy. Completed forms for patient follow up are not available for first quarter. There is usually a delay in UNOS in getting stats uploaded. Maggie spoke about department placement for renal transplant patients and went over the algorithm. It has been disseminated to all departments, and Wendy will be presenting it at the Nurses Leadership Meeting next week. Wendy noted that MediTech will be updated to automatically capture information for a renal transplant patient’s history. Pharmacy will monitor Sheila Brown 2nd ABO verification will now occur in Transplant Committee by an RN when the patient is ready to be listed in UNOs for Transplant candidacy. Kim Lawrence Maggie Fitzsimmons/Kim Lawrence/Wendy Escobedo Page 4 TOPIC / AGENDA ITEM COMMENTS/DISCUSSION/ RECOMMENDATIONS/MOTIONS (AIM) APPROVALS/ ACTIONS (Plan) RESPONSIBLE PARTY / FOLLOW UP (Do-Check-Act) high-risk patients for any possible immuno-suppressant medications. If a DSU bed isn’t available, the patient will be upgraded to MICU. Kim is doing in-services in DSU. The first in-service was called Fundamentals of Kidney Transplant. She is keeping a check-off list of who has been educated, with the goal of educating everyone on the list. There was a good turnout on July 11th. Night shift nurses need more training. The next in-service will be on Kidney Biopsy. Vivian will schedule more in-services. Dr. Ruzics will speak for about the first hour and a half at the transplant class on August 15th. Dr. Ruzics reported that PR had distributed copies of a Phys-Link article to physicians and management regarding important information on transplant patients and what St. Joseph is up to. We have been focusing on one-year graft survival. When a person hits the 3-year mark, it really is a successful transplantation milestone. Transplants are cheaper than dialysis, but the Federal government is on the hook for dialysis for $40B for whoever needs it. St. Joseph had the highest 30-year graft survival in California and exceeds the national one-year survival rates. Wendy expressed a need for help on the annual Rose Ceremony. We are looking at October 24th in the Healing Garden from 10:00 a.m. to 12:00 Noon. We are waiting to hear back from One Legacy about their availability. ADJOURNMENT Today’s meeting adjourned at 8:40 a.m. Next meeting: September 17 – CR-1 SFDB Reflection: Sheila Brown Recorded by: Pepper Harris, Executive Secretary Page 5 MEMBERS / CREDENTIAL TITLE ROLE/SPECIALTY Date 1/15/14 CR-7 Date 3/18/14 CR-7 Date 5/21/14 CR-1 Date 7/16/14 CR-1 Acevedo-Cosio, Lilia RN Cardiac Renal A Asano, Beth Clinical Dietician MD A Baitch, Brooke RN DSU X Boose-Shutes, Linda RN BSN Manager, DSU X Brown, Sheila Supervisor Lab X Coleongo, Luke RN MICU X Escobedo, Wendy Clinical Manager Renal Transplant Center A Faulkner, Judith Dietician RD X Fitzsimmons, Maggie DSU RN X Gull, Paula RNP TX Renal Center A Garakian, Margie Case Manager Renal Transplant Center A Hosseinpour, Peter Renal Trans. Specialist Pharmacy X Lawrence, Kim CC Transplant Renal Transplant Center X Messana, Anthony, RN Exec. Dir Renal Center X Munoz, Paz, RN BSN CN III Critical Care X Norman, Vivian, RN Educator Critical Care X O’Callaghan, Mary Social Worker Renal Transplant X Oneill, Jungmi RN Pulmonary Renal A Ruzics, Ervin MD Medical Director Renal Transplant Program X Sanchez, Esperanza Social Worker Pulmonary Renal A Satterfield, Mary Chem. Supervisor Lab A Saunders, Erin RN MICU Seidl, Gemma Manager Critical Care Sousa, Lucy RN Weil, Marya, RN, BSN Transplant Coordinator A X Renal Transplant Center X Date 9/17/14 CR-1 Date 11/19/14 CR-1